Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: A study by magnetic resonance imaging and 1H magnetic resonance spectroscopy

Toxicology Letters

Volumn 181, Issue 2, 2008, Pages 118-125

  Jiang, Yue Ming ^a   Long, Li Ling ^a   Zhu, Xia Yan ^a   Zheng, Hong ^a   Fu, Xue ^a   Ou, Shi Yan ^a   Wei, Dong Lu ^b   Zhou, Hai Lin ^b   Zheng, Wei ^c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Hechi Center for Diseases Control and Prevention   (China)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Hippocampus; Lead; Lipids; Magnetic resonance imaging; Magnetic resonance spectroscopy; N Acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; HYDROGEN; INOSINE; LEAD; LIPID; N ACETYLASPARTIC ACID;

ADULT; ANAMNESIS; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMISPHERE; HIPPOCAMPUS; HUMAN; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; SMELTER; WORK ENVIRONMENT;

ADULT; ASPARTIC ACID; CREATINE; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; LEAD; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OCCUPATIONAL EXPOSURE;

EID: 50849137848     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.07.009     Document Type: Article

References (56)

1. Alfano D.P., and Petit T.L. Neonatal lead exposure alters the dendritic development of hippocampal dentate granule cells. Exp. Neurol. 75 (1982) 275-288
2. Antuono P.G., Jones J.L., Wang Y., and Li S.J. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1) H-MRS at 0.5T. Neurology 56 (2001) 737-742
3. Barbosa Jr. F., Ramires I., Rodrigues M.H., Saint' Pierre T.D., Curtius A.J., Buzalaf M.R., Gerlach R.F., and Tanus-Santos J.E. Contrasting effects of age on the plasma/whole blood lead ratio in men and women with a history of lead exposure. Environ. Res. 102 (2006) 90-95
4. Bennet C., Bettaiya R., Rajanna S., Baker L., Yallapragada P.R., Brice J.J., White S.L., and Bokara K.K. Region specific increase in the antioxidant enzymes and lipid peroxidation products in the brain of rats exposed to lead. Free Radic. Res. 41 (2007) 267-273
5. Bernasconi N., Bernasconi A., Caramanos Z., Antel S.B., Andermann F., and Arnold D.L. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 126 (2003) 462-469
6. Bielarczyk H., Tian X., and Suszkiw J.B. Cholinergic denervation like changes in rat hippocampus following developmental lead exposure. Brain Res. 708 (1996) 108-115
7. Bolin C.M., Basha R., Cox D., Zawia N.H., Maloney B., Lahiri D.K., and Cardozo-Pelaez F. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J. 20 (2006) 788-790
8. Brand A., Richter-Landsberg C., and Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 15 (1993) 289-298
9. Campbell J.B., Wooley D.E., Vijayan V.K., and Overmann S.R. Morphometric effects of postnatal lead exposure on hippocampal development of the 15-day-old rat. Brain Res. 255 (1982) 595-612
10. Chernov M.F., Hayashi M., Izawa M., Ono Y., and Hori T. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. Int. J. Clin. Oncol. 11 (2006) 375-384
11. Chetty C.S., Vemuri M.C., Reddy G.R., and Suresh C. Protective effect of 17-beta-estradiol in human neurocellular models of lead exposure. Neurotoxicology 28 (2007) 396-401
12. Clark C.M., Davatzikos C., Borthakur A., Newberg A., Leight S., Lee V.M., and Trojanowski J.Q. Biomarkers for early detection of Alzheimer pathology. Neurosignals 16 (2008) 11-18
13. Costa L.G., and Fox D.A. A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Brain Res. 276 (1983) 259-266
14. Groenendaal F., Bianchi M.C., Battini R., Tosetti M., Boldrini A., de Vries L.S., and Cioni G. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants with Zellweger syndrome. Neuropediatrics 32 (2001) 23-27
15. Hertz-Picciotto I., Schramm M., Watt-Morse M., Chantala K., Anderson J., and Osterloh J. Patterns and determinants of blood lead during pregnancy. Am. J. Epidemiol. 152 (2000) 829-837
16. Huang W., Alexander G.E., Chang L., Shetty H.U., Krasuski J.S., Rapoport S.I., and Schapiro M.B. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H-MRS study. Neurology 57 (2001) 626-632
17. Jack Jr. C.R., Twomey C.K., Zinsmeister A.R., Sharbrough F.W., Petersen R.C., and Cascino G.D. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 172 (1989) 549-554
18. Jack Jr. C.R., Petersen R.C., O'Brien P.C., and Tangalos E.G. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42 (1992) 183-188
19. Jacobs D.E., and Nevin R. Validation of a 20-year forecast of US childhood lead poisoning: updated prospects for 2010. Environ. Res. 102 (2006) 352-364
20. Jeffon F., Block W., Trabver F., Keller E., Flacke S., Papassotiropoulos A., Lamerichs R., Heun R., and Schild H.H. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55 (2000) 684-688
21. Jenkins B.G., Koroshetz W.J., Beal M.F., and Rosen B.R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43 (1993) 2689-2695
22. Jett D.A., and Guilarte T.R. Developmental lead exposure alters NMDA and muscarinic cholinergic receptors in the rats hippocampus: an autoradiographic study. Neurotoxicology 16 (1995) 7-18
23. Jiang Y.M., Zheng W., Long L.L., Zhao W.J., Li X.G., Mo X.A., Lu J.P., Fu X., Li W.M., Liu S.F., Long Q.Y., Huang J.L., and Pira E. Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology 28 (2007) 126-135
24. Kantarci K., Weigand S.D., Petersen R.C., Boeve B.F., Knopman D.S., Gunter J., Reyes D., Shiung M., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., and Jack Jr. C.R. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 28 (2007) 1330-1339
25. Kiraly E., and Jones D.G. Dendtitic spine changes in rat hippocampal pyramidal cells after postnatal lead treatment: a Golgi study. Exp. Neurol. 77 (1982) 236-239
26. Lasky R.E., Luck M.L., and Parikh N.A. The effects of early lead exposure on the brains of adult rhesus monkeys: a volumetric MRI study. Toxicol. Sci. 85 (2005) 963-975
27. MacKay S., Meyerhoff D.J., Constans J.M., Norman D., Fein G., and Weiner M.W. Regional gray and white matter metabolite differences in subjects with AD with subcortical ischemic vascular dementia and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch. Neurol. 53 (1996) 167-174
28. Meng X.M., Ruan D.Y., Kang L.D., Zhu D.M., She J.Q., Luo L., Zheng Y., and Li X. Age-related morphological impairments in the rat hippocampus following developmental lead exposure: an MRI, LM and EM study. Environ. Toxicol. Pharmacol. 13 (2003) 187-197
29. Meng X.M., Zhu D.M., Ruan D.Y., She J.Q., and Luo L. Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children. Neurology 64 (2005) 1644-1647
30. Ona L.F., Alberto A.M., Prudente J.A., and Sigua G.C. Levels of lead in urban soils from selected cities in a central region of the Philippines. Environ. Sci. Pollut. Res. Int. 13 (2006) 177-183
31. Parekh P.P., Khwaja H.A., Khan A.R., et al. Lead content of petrol and diesel and its assessment in an urban environment. Environ. Monit. Assess. 74 (2002) 255-262
32. Pametti L., Tarducci R., Presciutti O., Lowenthal D.T., Pippi M., Palumbo B., Gobbi G., Pelliccioli G.P., and Senin U. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mech. Ageing Dev. 97 (1997) 9-14
33. Petit T.L., Alfano D.P., and LeBoutillier J.C. Early lead exposure and the hippocampus: a review and recent advances. Neurotoxicology 4 (1983) 79-94
34. Prince S.E., Woo S., Doraiswamy P.M., and Petrella J.R. Functional MRI in the early diagnosis of Alzheimer's disease: is it time to refocus?. Expert Rev. Neurother. 8 (2008) 169-175
35. Rose S.E., Zubicaray C.I., Wang D., Galloway G.J., Chalk J.B., Eagle S.C., Semple J., and Doddrell D.M. A 1H-MRS study of probable Alzheimer disease and normal aging: implication for longitudinal monitoring of dementia progression. Magn. Reson. Imaging 17 (1999) 291-299
36. Ross B.D. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine: myo-inositol and related metabolites. NMR Biomed. 4 (1991) 59-63
37. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., Kramer J., Jagust W., Miller B., Wolkowitz O.M., Yaffe K., and Weiner M.W. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 58 6 (2002) 928-935
38. Shiino A., Matsuda M., Morikawa S., Inubushi T., Akiguchi I., and Handa J. Proton magnetic resonance spectroscopy with dementia. Surg. Neurol. 39 (1993) 143-147
39. Shinno H., Inagaki T., Miyaoka T., Okazaki S., Kawamukai T., Utani E., Inami Y., and Horiguchi J. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease. J. Neurol. Sci. 260 (2007) 132-138
40. Shonk T.K., Moats R.A., Gifford P., Michaelis T., Mandigo J.C., Izumi J., and Ross B.D. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195 (1995) 65-72
41. Singh A.K., and Singh M. Lead decline in the Indian environment resulting from the petrol-lead phase-out programme. Sci. Total Environ. 368 (2006) 686-694
42. Stewart W.F., Schwartz B.S., Davatzikos C., Shen D., Liu D., Wu X., Todd A.C., Shi W., Bassett S., and Youssem D. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 66 (2006) 1476-1484
43. Teipel S.J., Pruessner J.C., Faltraco F., Born C., Rocha-Unold M., Evans A., Möller H.J., and Hampel H. Comprehensive dissection of the medial temporal lobe in AD: Measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J. Neurol. 253 (2006) 794-800
44. Trope I., Lopez-Villegas D., and Lenkinski R.E. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels. Pediatrics 101 6 (1998) 1066-1067
45. Trope I., Lopez-Villegas D., Cecil K.M., and Lenkinski R.E. Exposure to lead appears to selectively alter metabolism of cortical gray matter. Pediatrics 107 (2001) 1437-1442
46. 1H and 31P magnetic resonance spectroscopy of brain in degenerative cerebral disorders. Ann. Neurol. 31 (1992) 202-211
47. Webb J., Guimond A., Eldridge P., Chadwick D., Meunier J., Thirion J.P., and Roberts N. Automatic detection of hippocampal atrophy on magnetic resonance images. Magn. Reson. Imaging 17 (1999) 1149-1161
48. Weisskopf M.G., Hu H., Sparrow D., Lenkinski R.E., and Wright R.O. Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus. Environ. Health Perspect. 115 (2007) 519-523
49. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., Harry J., Rice D.C., Maloney B., Chen D., Lahiri D.K., and Zawia N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28 (2008) 3-9
50. Ye X., and Wong O. Lead exposure, lead poisoning, and lead regulatory standards in China, 1990-2005. Regul. Toxicol. Pharmacol. 46 (2006) 157-162
51. Zawia N.H., and Basha M.R. Environmental risk factors and the developmental basis for Alzheimer's disease. Rev. Neurosci. 16 (2005) 325-337
52. Zhao J.Q., and Zhou S.J. The central nervous system lead poisoning and MRI manifestation due to long-term dyeing. J. Clin. Res. 22 (2005) 346-348 (in Chinese)
53. Zheng W. Neurotoxicology of the brain barrier system: new implications. J. Toxicol. Clin. Toxicol. 39 (2001) 711-719
54. Zheng W., Perry D.F., Nelson D.L., and Aposhian H.V. Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J. 5 (1991) 2188-2193
55. Zheng W., Shen H., Blaner W.S., Zhao Q., Ren X., and Graziano J.H. Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus. Toxicol. Appl. Pharmacol. 139 (1996) 445-450
56. Zheng W., Lu Y.M., Lu G.Y., Zhao Q., Cheung O., and Blaner W.S. Transthyretin, thyroxin, and retinol-binding protein in human cerebrospinal fluid: effect of lead exposure. Toxicol. Sci. 61 (2001) 107-114